Washington, DC (March 24, 2020) – Yesterday the Trump Administration gave the drug corporation Gilead Sciences special monopoly protection on the promising COVID-19 treatment Remdesivir, giving them a green light to price gouge on a desperately needed treatment.
WASHINGTON (March 20, 2020) – Since the start of the coronavirus COVID-19 outbreak in the U.S. the Lower Drug Prices Now Coalition has been sounding the alarm about potential Big Pharma price gouging if President Trump and Health and Human Services Secretary Azar fail to enact price control measures that ensure affordability.
(Des Moines, Iowa, March 18, 2020) — We hear a lot from national sources about the continuing needs, concerns and spread of the COVID-19 virus. Today we heard from real Iowans representing Iowa government, small business, healthcare, and senior communities about the effects in Iowa.
Washington (March 12, 2020) – President Trump announced a new pilot project to cap insulin costs at $35 a month for people with diabetes participating in Medicare Part D. However, the proposed initiative is voluntary for drug makers and insurers and includes no controls on prices or negotiating power.
WASHINGTON, DC – On Thursday, March 5 at 1pm, the Lower Drug Prices Now (LDPN) coalition, representing millions of Americans angered by Big Pharma’s price-gouging, will join Sen. Chris Van Hollen, and Reps. Jan Schakowsky and Lloyd Doggett in demanding that President Trump and Secretary Azar guarantee that any coronavirus treatment or vaccine developed with taxpayer dollars be affordable for all.
WASHINGTON (March 3, 2020) – President Trump met with pharmaceutical corporate executives today about finding a vaccine and treatment for the COVID-19 coronavirus, which is approaching 90,000 infections worldwide and has killed six people in the United States.
“Big Pharma rang in the new year with a gift to itself: higher prices and bigger profits on over 200 prescription drugs. Drug corporations are congratulating themselves for keeping most hikes under 10 percent, but let’s be clear: for most hard working Americans, the household budget isn’t growing by 10, or even five percent this year. The upshot? Another year of higher co-pays and out-pocket costs, and another year of having to choose between taking on debt or paying for drugs we need.”